Strategies for minimizing immunosuppression: State of the Art

A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation

(2016) Satoru Todo et al.   HEPATOLOGY

HCV-Induced Immune Responses Influence the Development of Operational Tolerance After Liver Transplantation in Humans

(2014) F. Bohne et al.   Science Translational Medicine

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients

(2013) Carlos Benítez et al.   HEPATOLOGY

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

(2013) Rocío García de la Garza et al.   LIVER TRANSPLANTATION

Complete Immunosuppression Withdrawal and Subsequent Allograft Function Among Pediatric Recipients of Parental Living Donor Liver Transplants

(2012) Sandy Feng et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up

(2012) Tommaso Maria Manzia et al.   TRANSPLANT INTERNATIONAL

Acute Liver Transplant Rejection Upon Immunosuppression Withdrawal in a Tolerance Induction Trial: Potential Role of IFN-γ-secreting CD8+ T Cells

(2009) Vincent Donckier et al.   TRANSPLANTATION